[1] Goldsmith EC, Hoffman A, Morales MO, et al. Organization of fibroblasts in the heart[J]. Dev Dyn,2004,230(4):787-794. [2] Beltrami CA, Finato N, Rocco M, et al. Structural basis of end-stage failure inischemic cardiomyopathy in humans[J]. Circulation ,1994,89(1): 151-163. [3] Carroll EP, Janicki JS, Pick R, et al. Myocardial stiffness and reparative fibrosis following coronary embolisation in the rat[J]. Cardiovasc Res,1989,23(8): 655-661. [4] Jalil JE, Doering CW, Janicki JS, et al. Fibrillar collagen and myocardial stiffness in the intact hypertrophied rat left ventricle[J]. Circ Res, 1989,64(6):1041-1050. [5] Erickson JR, Joiner ML, Guan X, et al. A dynamic pathway for calcium-independent activation of CaMKII by methionine oxidation[J]. Cell, 2008,133(2):462-474. [6] Illario M, Monaco S, Cavallo AL, et al. Calcium-calmodulin-dependent kinase II (CaMKII) mediates insulin-stimulated proliferation and glucose uptake[J]. Cell Signal, 2009,21(5):786-792. [7] Li N, Wang C, Wu Y, et al. Ca(2+)/calmodulin-dependent protein kinase II promotes cell cycle progression by directly activating MEK1 and subsequently modulating p27 phosphorylation[J]. J Biol Chem, 2009, 284(5):3021-3027. [8] Zhu W, Woo AY, Yang D, et al. Activation of CaMKIIdeltaC is a common intermediate of diverse death stimuli-induced heart muscle cell apoptosis[J]. J Biol Chem, 2007,282(14):10833-10839. [9] Wu Y, Gao Z, Chen B, et al. In the cover: Calmodulin kinase II is required for fight or flight sinoatrial node physiology[J]. Proc Natl Acad Sci, 2009,106(14):5972-5977. [10] Zhang T Brown JH. Role of Ca2+/calmodulin-dependent protein kinase II in cardiac hypertrophy and heart failure[J]. Cardiol Res, 2004,63(3):476-486. [11] Zhang R, Khoo M, Wu Y, et al. Calmodulin kinase II inhibition protects against structural heart disease[J]. Nature Medicine, 2005,4(11):409-417. [12] Hempel P, Hoch B, Bartel S, et al. Hypertrophic phenotype of cardiac calcium/calmodulin-dependent protein kinase II is reversed by angiotensin converting enzyme inhibition[J]. Basic Res Cardiol, 2002,97(1):96-101. [13] Lijnen PJ, Petrov VV.Role of intracardiac renin-angiotensin aldo-sterone system in extracellularmatrix remodeling[J]. Methods Find Exp Clin Pharmacol, 2003,25(7):541-564. [14] Pauschinger M, Knopf D, Petschauer S, et al. Dilated cardiomyopathy is associated with significant changes in collagen type I/III ratio[J]. Circulation, 1999,99(21):2750-2756. [15] Schultz JEJ, Witt SA, Glascock BJ, et al. TGF-β1 mediates the hypertrophic cardio myocyte growth induced by angiotensin II[J]. J Clin Invest, 2002,109(6):787-796. [16] Janczewski AM, Kadokami T, Lemster B, et al. Morphological and functional changes in cardiac myocytes isolated from mice overexp-ressing TNF-alpha[J]. Am J Physiol Heart CircPhysiol, 2003,284(3):H960-H969. [17] Schnee JM,Hsueh WA. Angiotensin II, adhesion, and cardiac fibrosis[J]. Cardiovasc Res, 2000,46(2):264-268 [18] 董六一,陈志武.心肌缺血/再灌注损伤与炎症反应[J]. 中国临床药理学与治疗学, 2008,13(5):582-588. [19] Ishida A, Shigeri Y, Taniguchi T, et al. Protein phosphatases that regulate multifunctional Ca2+/calmodulin-dependent protein kinases: from biochemistry to pharmacology[J]. Pharmacol Ther, 2003,100(3):291-305. [20] Colomer JM, Mao L, Rockman HA, et al. Pressure overload selectively up-regulates Ca2+/calmodulin-dependent protein kinase II in vivo[J]. Mol Endocrinol, 2003,17(2):183-192. [21] Jorge A, Spadaccio GC , Langer J, et al. Electrostimulation induces cardiomyocyte predifferentiation of fibroblasts[J]. Biochem Biophys Res Commun, 2008,370(3):450-455. |